NCT00562055View on ClinicalTrials.gov

Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2007

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Atomoxetine

DRUG

PNU-165442G; [S,S]-reboxetine

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00562055 - Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder. | Biotech Hunter | Biotech Hunter